Diagnostic value and clinical significance of Ki-67, PI3K, and Fascin in patients with oral squamous cell carcinoma

Ki-67, PI3K, and Fascin are promising biomarkers for diagnosing and predicting the prognosis of OSCC. Their combined assessment could aid in early detection, identification of high-risk patients, and determination of appropriate treatment strategies. Further research is needed to fully understand the molecular mechanisms underlying their role in OSCC progression and to assess their clinical utility in patient management.